Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls.
about
Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia.Reduced tumorigenicity and pathogenicity of cervical carcinoma SiHa cells selected for resistance to cidofovirImmune therapy for human papillomaviruses-related cancers.Helper T lymphocyte response in the peripheral blood of patients with intraepithelial neoplasia submitted to immunotherapy with pegylated interferon-α.Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation.Peripheral blood lymphocytes from low-grade squamous intraepithelial lesions patients recognize vaccine antigens in the presence of activated dendritic cells, and produced high levels of CD8 + IFNγ + T cells and low levels of IL-2 when induced to prThe invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system.Peripheral helper lymphocytes produce interleukin 12 in cancer patients.Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesionsIdentification of promiscuous HPV16-derived T helper cell epitopes for therapeutic HPV vaccine design.A fluorescent microbead-based microfluidic immunoassay chip for immune cell cytokine secretion quantification.Change in cytokines in patients with warts after contact immunotherapy with squaric acid dibutylester.
P2860
Q33620823-9A172EA2-66B8-425B-9F78-6332A56B011BQ33643453-79F75E60-489D-4FE1-8A64-EBEECA1389E7Q34657561-EF7BC9BE-0636-4844-B7AB-02C90891011BQ35381122-379F31AC-A440-467E-ADA3-E4BE6F678A08Q35962518-38BA8A50-911D-4FC0-B992-510E1D188E12Q36123196-FBBA49D6-EE2A-406B-A6D3-9C3A0232F043Q36541450-A17289C1-6982-4771-9996-EA1897A1B24DQ36679789-FF23374D-AAFA-4D05-8FC4-EF99253DFC3CQ37511930-E42E9ECD-79A9-4E29-835B-7382C7A8AA85Q42218961-21F77562-A2CF-43CD-B1AC-7A595ECDB436Q50074476-2525B699-75DD-40F9-858E-2F9199DAEAA1Q51049840-96F99AD2-F817-43A6-BC94-9D43F0619E72
P2860
Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Cytokine release in HR-HPV(+) ...... pared with HR-HPV(-) controls.
@ast
Cytokine release in HR-HPV(+) ...... pared with HR-HPV(-) controls.
@en
type
label
Cytokine release in HR-HPV(+) ...... pared with HR-HPV(-) controls.
@ast
Cytokine release in HR-HPV(+) ...... pared with HR-HPV(-) controls.
@en
prefLabel
Cytokine release in HR-HPV(+) ...... pared with HR-HPV(-) controls.
@ast
Cytokine release in HR-HPV(+) ...... pared with HR-HPV(-) controls.
@en
P2093
P2860
P356
P1476
Cytokine release in HR-HPV(+) ...... pared with HR-HPV(-) controls.
@en
P2093
Aagje G Bais
Chris J L M Meijer
Ilse Beckmann
Marinus J C Eijkemans
Patricia C Ewing
Peter J F Snijders
Theo J M Helmerhorst
P2860
P356
10.1155/2007/24147
P577
2007-01-01T00:00:00Z